Come up with a name for your new list and we'll add to it:
Catena Pharmaceuticals raised a round of funding on October 20, 2008. Investors include
Golden Pine Ventures.
Catena Pharmaceuticals is focused on the development and commercialization of GPCR antagonists, particularly in the areas of cancer and fibrotic disease. Catena's chemistry is capable of affecting a…